ArticleCardiovascular therapeutics2019

Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors.

Helena Norberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.